MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1272/jnms.jnms.2023_90-207

Медицинская библиотека · Journal of Nippon Medical School = Nippon Ika Daigaku zasshi · 2023

Change in Serum KL-6 Level during Biologic Treatment for Psoriasis.

Hoashi Toshihiko, Miyazaki Shun, Ozaki Saeko, Ichiyama Susumu, Ito Michiko, Kanda Naoko, Saeki Hidehisa

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

We previously analyzed data from blood examination screenings, including serum Krebs von den Lungen (KL) -6 level, before starting biologic treatment for psoriasis in a real-world setting. However, we did not follow change in KL-6 level after the initiation of biologics. Furthermore, there has been no follow-up study of certolizumab pegol, risankizumab, or tildrakizumab. This study evaluated change in serum KL-6 levels in patients during treatment with biologics, including certolizumab pegol, risankizumab, and tildrakizumab.

METHODS

We analyzed data from 111 patients. Change in KL-6 level was regarded as significant if it increased to greater than 500 U/mL at least once and if the maximum level after treatment with biologics was at least 1.5 times that of the baseline level.

RESULTS

KL-6 level significantly changed during treatment with TNF inhibitors, IL-17 inhibitors, and IL-23 inhibitors in 9 (20.9%), 2 (6.3%), and 2 (5.6%) patients, respectively. Mean age, mean baseline KL-6 level, and frequency of TNF inhibitor use were higher in patients with a significant change in KL-6 level than those in patients without a significant change. Ten patients had minor interstitial changes on chest CT scans but no clinical signs suggesting interstitial pneumonia.

CONCLUSIONS

Older patients with psoriasis and high baseline KL-6 levels must be carefully monitored during treatment with biologics, especially TNF inhibitors. Monitoring of KL-6 level and chest CT scans is necessary to exclude the possibility of drug-induced interstitial pneumonia.

Для цитирования: Hoashi Toshihiko, Miyazaki Shun, Ozaki Saeko, Ichiyama Susumu, Ito Michiko, Kanda Naoko, Saeki Hidehisa. Change in Serum KL-6 Level during Biologic Treatment for Psoriasis.. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 2023. DOI: 10.1272/jnms.jnms.2023_90-207.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.